Nifty
Sensex
:
:
9915.25
32028.89
41.95 (0.42%)
124.49 (0.39%)

Pharmaceuticals & Drugs

Rating :
65/99

BSE: 500302 | NSE: PEL

2918.05
-30.75 (-1.04%)
21-Jul-2017 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 2936.00
  • 2950.50
  • 2900.00
  • 2948.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 81123
  • 2367.21
  • 3088.95
  • 1366.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 50,843.99
  • 40.62
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 79,754.07
  • 0.71%
  • 3.42

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.43%
  • 1.32%
  • 11.7%
  • FII
  • DII
  • Others
  • 2.64%
  • 0.93%
  • 31.98%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Jun 16
Jun 15
Var%
Net Sales
2,462.64
1,733.51
42.06%
2,341.74
1,858.68
25.99%
1,966.15
1,544.11
27.33%
1,776.22
1,473.59
20.54%
Expenses
1,430.29
1,265.87
12.99%
1,256.75
1,230.47
2.14%
1,222.50
1,068.15
14.45%
1,138.07
1,173.14
-2.99%
EBITDA
1,032.35
467.64
120.76%
1,084.99
628.21
72.71%
743.65
475.96
56.24%
638.15
300.45
112.40%
EBIDTM
41.92%
26.98%
46.33%
33.80%
37.82%
30.82%
35.93%
20.39%
Other Income
86.32
39.18
120.32%
52.08
31.03
67.84%
42.34
50.92
-16.85%
53.01
121.33
-56.31%
Interest
589.72
303.88
94.06%
590.63
250.21
136.05%
455.23
214.87
111.86%
395.40
169.81
132.85%
Depreciation
121.54
90.05
34.97%
110.11
87.26
26.19%
73.28
77.47
-5.41%
76.77
72.66
5.66%
PBT
399.27
185.25
115.53%
434.52
306.75
41.65%
257.48
225.47
14.20%
218.99
176.71
23.93%
Tax
103.18
37.60
174.41%
75.76
24.87
204.62%
3.12
23.47
-86.71%
46.06
17.25
167.01%
PAT
296.09
147.65
100.54%
358.76
281.88
27.27%
254.36
202.00
25.92%
172.93
159.46
8.45%
PATM
12.02%
8.52%
15.32%
15.17%
12.94%
13.08%
9.74%
10.82%
EPS
18.02
10.45
72.44%
23.42
18.64
25.64%
17.75
14.25
24.56%
13.38
11.75
13.87%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
8,503.65
6,609.89
5,122.61
4,502.74
3,520.19
2,158.87
1,673.08
3,624.47
3,244.81
2,848.28
Net Sales Growth
28.65%
29.03%
13.77%
27.91%
63.06%
29.04%
-53.84%
11.70%
13.92%
 
Cost Of Goods Sold
1,401.10
1,339.38
1,314.40
1,195.02
1,113.57
927.24
694.03
1,397.21
1,236.54
1,092.96
Gross Profit
7,102.55
5,270.51
3,808.21
3,307.72
2,406.62
1,231.63
979.05
2,227.26
2,008.27
1,755.32
GP Margin
83.52%
79.74%
74.34%
73.46%
68.37%
57.05%
58.52%
61.45%
61.89%
61.63%
Total Expenditure
5,004.51
4,738.48
4,237.46
3,867.83
3,105.38
2,159.80
2,465.72
2,944.25
2,699.75
2,331.15
Power & Fuel Cost
101.03
98.86
92.15
89.35
82.12
65.82
59.82
79.26
81.07
78.74
% Of Sales
1.19%
1.50%
1.80%
1.98%
2.33%
3.05%
3.58%
2.19%
2.50%
2.76%
Employee Cost
1,793.87
1,689.83
1,294.76
1,136.95
796.53
436.42
411.65
573.32
488.37
461.93
% Of Sales
21.10%
25.57%
25.28%
25.25%
22.63%
20.22%
24.60%
15.82%
15.05%
16.22%
Manufacturing Exp.
401.93
507.78
583.17
557.39
520.26
317.34
145.94
186.33
210.20
205.99
% Of Sales
4.73%
7.68%
11.38%
12.38%
14.78%
14.70%
8.72%
5.14%
6.48%
7.23%
General & Admin Exp.
769.67
597.37
524.38
473.46
306.39
201.10
202.80
300.12
274.64
216.95
% Of Sales
9.05%
9.04%
10.24%
10.51%
8.70%
9.32%
12.12%
8.28%
8.46%
7.62%
Selling & Distn. Exp.
284.43
226.02
269.81
245.82
194.24
121.27
110.50
250.27
202.98
146.95
% Of Sales
3.34%
3.42%
5.27%
5.46%
5.52%
5.62%
6.60%
6.91%
6.26%
5.16%
Miscellaneous Exp.
252.48
279.24
158.79
169.84
92.27
90.61
840.98
157.74
205.95
146.95
% Of Sales
2.97%
4.22%
3.10%
3.77%
2.62%
4.20%
50.27%
4.35%
6.35%
4.48%
EBITDA
3,499.14
1,871.41
885.15
634.91
414.81
-0.93
-792.64
680.22
545.06
517.13
EBITDA Margin
41.15%
28.31%
17.28%
14.10%
11.78%
-0.04%
-47.38%
18.77%
16.80%
18.16%
Other Income
403.65
243.31
254.52
225.43
196.17
472.23
1,317.52
152.92
158.27
70.93
Interest
2,030.98
938.77
510.60
1,049.58
575.01
215.46
88.83
183.81
198.40
86.61
Depreciation
381.70
327.44
289.87
246.90
209.56
129.29
95.86
142.65
119.57
94.73
PBT
1,490.11
848.51
339.20
-436.14
-173.59
126.55
340.19
506.68
385.36
406.72
Tax
228.12
103.19
344.96
62.75
24.76
5.63
3,679.71
18.03
21.94
37.66
Tax Rate
15.41%
11.54%
11.36%
-14.43%
-12.85%
4.66%
22.22%
3.61%
6.44%
10.10%
PAT
1,251.75
791.32
2,690.68
-498.28
-223.06
111.50
12,883.36
481.90
316.25
333.78
PAT before Minority Interest
1,252.04
790.99
2,690.39
-497.52
-217.48
115.26
12,883.67
481.74
318.81
335.13
Minority Interest
-0.29
0.33
0.29
-0.76
-5.58
-3.76
-0.31
0.16
-2.56
-1.35
PAT Margin
14.72%
11.97%
52.53%
-11.07%
-6.34%
5.16%
770.04%
13.30%
9.75%
11.72%
PAT Growth
58.19%
-70.59%
639.99%
-123.38%
-300.05%
-99.13%
2573.45%
52.38%
-5.25%
 
Unadjusted EPS
72.57
55.10
165.20
-29.10
-13.20
6.60
572.20
21.00
15.10
15.90

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
14,882.57
12,422.10
11,735.93
9,321.06
10,723.56
11,242.03
11,836.42
1,684.89
1,317.07
1,092.59
Share Capital
34.51
34.51
34.51
34.51
34.51
34.51
33.58
41.80
41.80
41.80
Total Reserves
14,848.06
12,387.59
11,701.42
9,286.55
10,689.05
11,207.52
11,802.84
1,643.09
1,275.27
1,050.79
Non-Current Liabilities
18,586.88
12,403.97
7,817.04
6,709.95
1,598.43
1,180.37
1,155.32
1,351.74
1,411.63
806.00
Secured Loans
11,714.16
3,193.91
1,539.08
504.42
609.44
208.81
232.25
575.36
451.66
346.90
Unsecured Loans
2,781.53
4,387.29
2,248.40
2,175.18
551.60
439.41
424.30
719.60
887.42
369.43
Long Term Provisions
4,499.94
4,787.13
4,048.77
4,026.55
346.63
346.81
258.89
0.00
0.00
0.00
Current Liabilities
18,962.28
10,613.26
5,694.05
9,490.09
11,764.78
6,111.55
4,693.23
1,041.96
1,070.46
771.80
Trade Payables
764.29
524.33
509.57
485.11
539.18
412.97
339.97
442.50
423.67
358.50
Other Current Liabilities
5,563.12
2,962.04
1,400.84
1,369.74
1,223.68
764.05
407.35
116.61
207.00
109.07
Short Term Borrowings
12,079.48
6,869.08
2,829.32
6,400.74
6,018.77
1,014.45
69.32
0.00
0.00
0.00
Short Term Provisions
555.39
257.81
954.32
1,234.50
3,983.15
3,920.08
3,876.59
482.85
439.79
304.23
Total Liabilities
52,444.94
35,473.01
25,276.13
25,521.10
24,098.57
18,544.29
17,690.73
4,078.59
3,806.61
2,675.25
Net Block
9,972.70
8,001.11
7,065.23
6,191.00
5,709.41
1,827.78
1,443.72
1,977.35
1,946.44
1,200.45
Gross Block
10,552.42
10,074.29
8,876.19
7,671.41
6,889.36
2,489.08
1,903.21
2,753.68
2,605.90
1,698.74
Accumulated Depreciation
579.72
2,073.18
1,810.96
1,480.41
1,179.95
661.30
459.49
776.33
659.46
498.29
Non Current Assets
43,270.72
30,547.18
19,911.89
21,149.44
16,397.63
13,307.38
8,036.06
2,145.56
2,066.92
1,323.79
Capital Work in Progress
879.63
366.13
277.14
491.07
371.96
260.77
138.45
135.66
92.65
58.09
Non Current Investment
21,716.66
14,172.84
6,820.88
9,249.93
6,969.82
6,577.86
380.86
32.55
27.83
65.25
Long Term Loans & Adv.
10,689.46
7,484.85
5,469.79
5,000.80
1,109.37
441.64
269.44
0.00
0.00
0.00
Other Non Current Assets
12.27
522.25
278.85
216.64
2,237.07
4,199.33
5,803.59
0.00
0.00
0.00
Current Assets
9,163.41
4,925.83
5,364.24
4,371.66
7,700.94
5,236.91
9,654.67
1,933.03
1,739.69
1,351.46
Current Investments
3,463.95
627.38
947.01
195.85
906.94
386.22
1,100.72
0.00
0.00
0.00
Inventories
723.07
735.44
674.94
652.30
541.82
465.60
382.56
469.45
483.36
403.20
Sundry Debtors
1,107.74
926.21
831.73
719.77
597.57
436.65
374.74
437.61
486.63
445.72
Cash & Bank
1,540.90
441.79
460.08
333.60
287.52
57.82
1,770.26
41.18
94.55
55.10
Other Current Assets
2,327.75
152.73
75.63
833.71
5,367.09
3,890.62
6,026.39
984.79
675.15
447.44
Short Term Loans & Adv.
2,223.17
2,042.28
2,374.85
1,636.43
4,048.46
3,785.30
4,114.27
976.93
665.13
405.08
Net Current Assets
-9,798.87
-5,687.43
-329.81
-5,118.43
-4,063.84
-874.64
4,961.44
891.07
669.23
579.66
Total Assets
52,444.94
35,473.01
25,276.13
25,521.10
24,098.57
18,544.29
17,690.73
4,078.59
3,806.61
2,675.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
-10,039.29
-6,777.33
-2,206.85
-1,604.43
-1,570.46
-684.78
-4,537.14
432.92
372.77
335.90
PBT
1,320.21
848.51
339.20
-436.14
-173.59
120.89
16,414.55
499.77
340.75
372.79
Adjustment
822.55
716.34
342.03
1,092.38
632.39
-140.32
-16,451.69
279.28
248.30
193.71
Changes in Working Capital
-11,716.05
-7,951.55
-2,495.18
-2,132.96
-1,880.13
-585.24
-314.67
-231.56
-85.31
-147.44
Cash after chg. in Working capital
-9,573.29
-6,386.70
-1,813.95
-1,476.72
-1,421.33
-604.67
-351.81
547.49
503.74
419.06
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-456.05
-347.95
-344.27
-125.70
-130.00
-74.45
-3,540.60
-107.66
-86.36
-49.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-9.95
-42.68
-48.63
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,420.20
-876.78
6,177.07
1,482.91
-1,664.46
-1,581.80
9,157.64
-157.46
-377.12
-280.94
Net Fixed Assets
-118.35
-206.99
4.99
-74.35
-89.52
-357.29
614.10
-146.67
-289.09
13.48
Net Investments
-125.14
-6,926.39
1,363.48
-1,963.06
-2,512.81
-5,527.04
-1,390.60
-62.67
-1.72
-1.76
Others
-2,176.71
6,256.60
4,808.60
3,520.32
937.87
4,302.53
9,934.14
51.88
-86.31
-292.66
Cash from Financing Activity
13,570.46
7,619.87
-3,864.63
125.84
3,280.68
640.17
-2,984.62
-313.57
-9.75
-55.98
Net Cash Inflow / Outflow
1,110.97
-34.24
105.59
4.32
45.76
-1,626.41
1,635.88
-38.11
-14.10
-1.02
Opening Cash & Equivalents
226.57
447.01
325.18
268.65
52.98
1,678.88
38.12
94.55
55.10
50.59
Closing Cash & Equivalent
1,364.21
422.31
447.01
325.18
268.65
52.98
1,678.88
41.18
94.55
55.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
861.88
719.91
680.15
540.19
621.48
651.52
704.97
80.62
63.02
52.28
ROA
2.85%
2.60%
10.59%
-2.01%
-1.02%
0.64%
118.37%
12.22%
9.84%
13.09%
ROE
9.17%
6.55%
25.55%
-4.96%
-1.98%
1.00%
190.57%
32.10%
26.46%
31.31%
ROCE
9.49%
7.68%
18.70%
3.30%
2.41%
2.60%
213.86%
24.26%
24.15%
26.00%
Fixed Asset Turnover
0.83
0.70
0.62
0.62
0.76
0.99
0.72
1.37
1.54
1.78
Receivable days
43.43
48.30
54.96
53.08
53.19
67.98
88.00
45.82
51.38
50.61
Inventory Days
31.14
38.75
47.02
48.12
51.81
71.06
92.29
47.24
48.86
52.50
Payable days
52.53
44.51
46.87
53.98
57.39
67.88
92.24
58.77
60.19
57.01
Cash Conversion Cycle
22.04
42.54
55.11
47.22
47.60
71.16
88.05
34.29
40.05
46.10
Total Debt/Equity
2.05
1.31
0.62
1.02
0.72
0.18
0.06
0.77
1.02
0.66
Interest Cover
1.73
1.95
6.94
0.59
0.66
1.56
187.46
3.72
2.72
5.30

News Update


  • Piramal Enterprises enters into JVA with Bain Capital Credit India Investments
    20th Jul 2017, 09:21 AM

    The company has proposed to transfer 50% equity shares held in PARPL to Bain Capital Credit India Investments

    Read More
  • Piramal Enterprises eyes expanding footprint in US, Europe: Report
    12th Jul 2017, 09:36 AM

    The company will continue to add more generic hospital products both organically and inorganically

    Read More
  • Piramal Enterprises’ arm sanctions Rs 700 crore to ACME Solar Holdings
    6th Jul 2017, 09:43 AM

    ACME Solar Holdings is a Delhi-based Independent Power Producer with a portfolio of over 1.8 GW of solar power across the 14 states

    Read More
  • Piramal Enterprises invests Rs 485 crore in Apollo LogiSolutions: Report
    30th Jun 2017, 09:28 AM

    The investments were made through the corporate finance group of Piramal Finance

    Read More
  • Piramal Enterprises gets nod to raise up to Rs 500 crore
    27th Jun 2017, 12:12 PM

    These NCDs are proposed to be listed on Wholesale Debt Market segment of NSE

    Read More
  • Piramal Enterprises gets nod to raise up to Rs 125 crore
    23rd Jun 2017, 13:57 PM

    The Administrative Committee constituted by the Board of Directors of the Company at its meeting held on June 23, 2017 approved for the same

    Read More
  • Piramal Enterprises gets nod to raise up to Rs 1,100 crore on private placement basis
    20th Jun 2017, 16:05 PM

    These NCDs are proposed to be listed on Wholesale Debt Market segment of NSE

    Read More
  • Piramal Enterprises gets nod to raise up to Rs 600 crore on private placement basis
    14th Jun 2017, 15:38 PM

    These NCDs are proposed to be listed on Wholesale Debt Market segment of NSE

    Read More
  • Piramal's consumer products division launches new variants of Heritage Brand Lacto Calamine
    14th Jun 2017, 10:06 AM

    The new variants are clay-based Kaolin with three-way action, which only removes excess oil, retaining essential oils, and protecting the skin from bacterial infections

    Read More
  • Piramal Enterprises plans to raise up to Rs 600 crore on private placement basis
    12th Jun 2017, 09:38 AM

    The meeting of the Administrative Committee of the board of directors will be held on June 14, 2017, to consider and approve for the same

    Read More
  • Piramal Enterprises’ arm invests Rs 1,100 crore in Embassy group's projects
    7th Jun 2017, 15:38 PM

    The funding has been done for development of housing and commercial projects in Bengaluru, Chennai and Hyderabad

    Read More
  • Piramal Enterprises’ arm invests Rs 565 crore in two auto component makers
    30th May 2017, 15:19 PM

    The company has invested Rs 275 crore in RSB Group and Rs 290 crore in Indoshell Mould

    Read More
  • Piramal Enterprises plans to raise Rs 5,000 crore
    13th May 2017, 09:55 AM

    The company has received shareholders’ approval for the same

    Read More
  • Piramal Enterprises - Quarterly Results
    12th May 2017, 12:00 AM

    Read More
  • Piramal Enterprises plans to raise Rs 4,000 crore: Report
    10th May 2017, 09:24 AM

    The funds will help the company to leverage its balance sheet to raise cheaper debt up to Rs 12,000 crore to lend to Indian companies

    Read More
  • Piramal Enterprises partners with IPA to educate stakeholders- Responsible Self-Care
    20th Apr 2017, 09:19 AM

    As part of the activity, Piramal Enterprises and IPA jointly will organize Chemist Awareness Programmes (CAP) in different locations across India

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.